Spruce Biosciences, Inc.
SPRB
$89.20
$6.097.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.21M | -2.07M | -14.04M | -23.56M | -8.67M |
| Total Depreciation and Amortization | 3.00K | 7.00K | 6.00K | 9.00K | 10.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 585.00K | -472.00K | 451.00K | 1.03M | 1.20M |
| Change in Net Operating Assets | 2.31M | -6.30M | 857.00K | 1.85M | -1.76M |
| Cash from Operations | -5.32M | -8.83M | -12.73M | -20.68M | -9.22M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -405.00K | -406.00K | -405.00K | -406.00K | -405.00K |
| Issuance of Common Stock | 3.00K | -- | -- | 14.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -233.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 6.00K | -6.00K | -- | -- |
| Cash from Financing | -402.00K | -400.00K | -411.00K | -625.00K | -405.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.72M | -9.23M | -13.14M | -21.30M | -9.63M |